Safety and Efficacy Workplace Environment Study of Lisdexamfetamine Dimesylate (LDX) in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)

Status:
Completed

Trial end date:
2008-12-20

Target enrollment:

Participant gender:

To evaluate the efficacy of LDX compared to placebo in adults with ADHD in the adult workplace environment (AWE) setting

Phase 3

Shire

Lisdexamfetamine Dimesylate